Skip to main content
Erschienen in: AIDS and Behavior 1/2024

26.08.2023 | Original Paper

Perceptions of Health, Body Size, and Nutritional Risk Factors for Obesity in People with HIV in South Africa

verfasst von: Jennifer Manne-Goehler, Nicholas Rahim, Eva van Empel, Rebecca de Vlieg, Grace Chamberlin, Amanda Ihama, Alison Castle, Smart Mabweazara, Willem D. F. Venter, Nomathemba Chandiwana, Naomi S. Levitt, Mark Siedner

Erschienen in: AIDS and Behavior | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Metabolic disease is increasing in people with HIV (PWH) in South Africa, but little is known about self-perceptions of body size, health, and nutritional behavior in this population. We performed a cross-sectional analysis of individual-level data from the 2016 South Africa Demographic and Health Survey. This survey measured HIV serostatus and body mass index (BMI). We categorized participants into six BMI groups: 18.5–22 kg/m2, 22–25 kg/m2, 25–27.5 kg/m2, 27.5–30 kg/m2, 30–35 kg/m2, and ≥ 35 kg/m2 and stratified them by HIV serostatus. Our outcomes were self-reported (1) body size and (2) health status among all participants, and intake of (3) chips and (4) sugar-sweetened beverages (SSB) in PWH. We described these metrics and used multivariable regression to evaluate the relationship between the nutritional behaviors and BMI ≥ 25 kg/m2 in PWH only, adjusting for age, sex, educational attainment, and household wealth quintile. Of 6138 participants, 1163 (19.7%) were PWH. Among PWH, < 10% with a BMI 25–30 kg/m2, < 20% with a BMI 30–35 kg/m2 and < 50% with a BMI ≥ 35 kg/m2 self-reported as overweight or obese. PWH reported being in poor health at higher rates than those without HIV at each BMI category except ≥ 35 kg/m2. In adjusted models, SSB consumption was associated with BMI ≥ 25 kg/m2 (1.13 [1.01–1.25], t-statistic = 2.14, p = 0.033) in PWH. Perceptions of body size may challenge efforts to prevent weight gain in PWH in South Africa. SSB intake reduction should be further explored as a modifiable risk factor for obesity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Flood D, Seiglie JA, Dunn M, et al. The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults. Lancet Healthy Longev. 2021;2(6):e340–51.CrossRefPubMedPubMedCentral Flood D, Seiglie JA, Dunn M, et al. The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults. Lancet Healthy Longev. 2021;2(6):e340–51.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Manne-Goehler J, Atun R, Stokes A, et al. Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries. Lancet Diabetes Endocrinol. 2016;4(11):903–12.CrossRefPubMed Manne-Goehler J, Atun R, Stokes A, et al. Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries. Lancet Diabetes Endocrinol. 2016;4(11):903–12.CrossRefPubMed
4.
Zurück zum Zitat Stokes A, Berry KM, McHiza Z, et al. Prevalence and unmet need for diabetes care across the care continuum in a national sample of South African adults: evidence from the SANHANES-1, 2011–2012. PLoS ONE. 2017;12(10): e0184264.CrossRefPubMedPubMedCentral Stokes A, Berry KM, McHiza Z, et al. Prevalence and unmet need for diabetes care across the care continuum in a national sample of South African adults: evidence from the SANHANES-1, 2011–2012. PLoS ONE. 2017;12(10): e0184264.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Venter WDF, Moorhouse M, Sokhela S, et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381(9):803–15.CrossRefPubMed Venter WDF, Moorhouse M, Sokhela S, et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381(9):803–15.CrossRefPubMed
7.
Zurück zum Zitat Verburgh ML, Wit F, Boyd A, Verboeket SO, Reiss P, van der Valk M. One in 10 virally suppressed persons with HIV in the Netherlands experiences >/=10% weight gain after switching to tenofovir alafenamide and/or integrase strand transfer inhibitor. Open Forum Infect Dis. 2022;9(7):ofac91.CrossRef Verburgh ML, Wit F, Boyd A, Verboeket SO, Reiss P, van der Valk M. One in 10 virally suppressed persons with HIV in the Netherlands experiences >/=10% weight gain after switching to tenofovir alafenamide and/or integrase strand transfer inhibitor. Open Forum Infect Dis. 2022;9(7):ofac91.CrossRef
9.
Zurück zum Zitat Milic J, Renzetti S, Ferrari D, et al. Relationship between weight gain and insulin resistance in people living with HIV switching to integrase strand transfer inhibitors-based regimens. AIDS. 2022;36(12):1643–53.CrossRefPubMed Milic J, Renzetti S, Ferrari D, et al. Relationship between weight gain and insulin resistance in people living with HIV switching to integrase strand transfer inhibitors-based regimens. AIDS. 2022;36(12):1643–53.CrossRefPubMed
10.
Zurück zum Zitat Herrin M, Tate JP, Akgun KM, et al. Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals. J Acquir Immune Defic Syndr. 2016;73(2):228–36.CrossRefPubMedPubMedCentral Herrin M, Tate JP, Akgun KM, et al. Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals. J Acquir Immune Defic Syndr. 2016;73(2):228–36.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Esber AL, Chang D, Iroezindu M, et al. Weight gain during the dolutegravir transition in the African Cohort Study. J Int AIDS Soc. 2022;25(4): e25899.CrossRefPubMedPubMedCentral Esber AL, Chang D, Iroezindu M, et al. Weight gain during the dolutegravir transition in the African Cohort Study. J Int AIDS Soc. 2022;25(4): e25899.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Bailin SS, Koethe JR. Diabetes in HIV: the Link to Weight Gain. Curr HIV/AIDS Rep. 2022;20(1):9–18.CrossRefPubMed Bailin SS, Koethe JR. Diabetes in HIV: the Link to Weight Gain. Curr HIV/AIDS Rep. 2022;20(1):9–18.CrossRefPubMed
13.
Zurück zum Zitat McCann K, Shah S, Hindley L, et al. Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes. AIDS. 2021;35(10):1657–65.CrossRefPubMed McCann K, Shah S, Hindley L, et al. Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes. AIDS. 2021;35(10):1657–65.CrossRefPubMed
15.
Zurück zum Zitat Manne-Goehler J, Siedner MJ, Montana L, et al. Hypertension and diabetes control along the HIV care cascade in rural South Africa. J Int AIDS Soc. 2019;22(3): e25213.CrossRefPubMedPubMedCentral Manne-Goehler J, Siedner MJ, Montana L, et al. Hypertension and diabetes control along the HIV care cascade in rural South Africa. J Int AIDS Soc. 2019;22(3): e25213.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Magodoro IM, Okello S, Dungeni M, Castle AC, Mureyani S, Danaei G. Association between HIV and prevalent hypertension and diabetes mellitus in South Africa: analysis of a nationally representative cross-sectional survey. Int J Infect Dis. 2022;121:217–25.CrossRefPubMedPubMedCentral Magodoro IM, Okello S, Dungeni M, Castle AC, Mureyani S, Danaei G. Association between HIV and prevalent hypertension and diabetes mellitus in South Africa: analysis of a nationally representative cross-sectional survey. Int J Infect Dis. 2022;121:217–25.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Okop KJ, Mukumbang FC, Mathole T, Levitt N, Puoane T. Perceptions of body size, obesity threat and the willingness to lose weight among black South African adults: a qualitative study. BMC Public Health. 2016;16:365.CrossRefPubMedPubMedCentral Okop KJ, Mukumbang FC, Mathole T, Levitt N, Puoane T. Perceptions of body size, obesity threat and the willingness to lose weight among black South African adults: a qualitative study. BMC Public Health. 2016;16:365.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Gradidge PJ, Golele P, Cohen E. Body weight perceptions and obesity amongst university employed South African women. Women Health. 2020;60(8):851–62.CrossRefPubMed Gradidge PJ, Golele P, Cohen E. Body weight perceptions and obesity amongst university employed South African women. Women Health. 2020;60(8):851–62.CrossRefPubMed
19.
Zurück zum Zitat Teufel F, Seiglie JA, Geldsetzer P, et al. Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults. Lancet. 2021;398(10296):238–48.CrossRefPubMedPubMedCentral Teufel F, Seiglie JA, Geldsetzer P, et al. Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults. Lancet. 2021;398(10296):238–48.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Motala AA, Esterhuizen T, Pirie FJ, Omar MA. The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South african community. Diabetes Care. 2011;34(4):1032–7.CrossRefPubMedPubMedCentral Motala AA, Esterhuizen T, Pirie FJ, Omar MA. The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South african community. Diabetes Care. 2011;34(4):1032–7.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Caleyachetty R, Barber TM, Mohammed NI, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2021;9(7):419–26.CrossRefPubMedPubMedCentral Caleyachetty R, Barber TM, Mohammed NI, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2021;9(7):419–26.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Essman M, Taillie LS, Frank T, Ng SW, Popkin BM, Swart EC. Taxed and untaxed beverage intake by South African young adults after a national sugar-sweetened beverage tax: a before-and-after study. PLoS Med. 2021;18(5): e1003574.CrossRefPubMedPubMedCentral Essman M, Taillie LS, Frank T, Ng SW, Popkin BM, Swart EC. Taxed and untaxed beverage intake by South African young adults after a national sugar-sweetened beverage tax: a before-and-after study. PLoS Med. 2021;18(5): e1003574.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Malik VS, Hu FB. The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases. Nat Rev Endocrinol. 2022;18(4):205–18.CrossRefPubMedPubMedCentral Malik VS, Hu FB. The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases. Nat Rev Endocrinol. 2022;18(4):205–18.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Bosire EN, Cohen E, Erzse A, Goldstein SJ, Hofman KJ, Norris SA. “I’d say I’m fat, I’m not obese”: obesity normalisation in urban-poor South Africa. Public Health Nutr. 2020;23(9):1515–26.CrossRefPubMedPubMedCentral Bosire EN, Cohen E, Erzse A, Goldstein SJ, Hofman KJ, Norris SA. “I’d say I’m fat, I’m not obese”: obesity normalisation in urban-poor South Africa. Public Health Nutr. 2020;23(9):1515–26.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Manafe M, Chelule PK, Madiba S. Views of own body weight and the perceived risks of developing obesity-66 and NCDs in South African adults. Int J Environ Res Public Health. 2021;18(21):11265.CrossRefPubMedPubMedCentral Manafe M, Chelule PK, Madiba S. Views of own body weight and the perceived risks of developing obesity-66 and NCDs in South African adults. Int J Environ Res Public Health. 2021;18(21):11265.CrossRefPubMedPubMedCentral
Metadaten
Titel
Perceptions of Health, Body Size, and Nutritional Risk Factors for Obesity in People with HIV in South Africa
verfasst von
Jennifer Manne-Goehler
Nicholas Rahim
Eva van Empel
Rebecca de Vlieg
Grace Chamberlin
Amanda Ihama
Alison Castle
Smart Mabweazara
Willem D. F. Venter
Nomathemba Chandiwana
Naomi S. Levitt
Mark Siedner
Publikationsdatum
26.08.2023
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2024
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-023-04152-7

Weitere Artikel der Ausgabe 1/2024

AIDS and Behavior 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.